SNCA and Parkinson disease: Collectively, our results suggest that osmotin, a potential adiponectin receptor agonist, can enhance the clearance of α-synuclein and protect against MPTP/α-synuclein-induced neuroinflammation and PD-like pathological neurodegeneration via the AMPK/MAPK pathways in the brains of PD model mice.